Background. Patients with tetralogy of Fallot, pulmonary atresia, and diminutive pulmonary arteries are a high-risk group for whom there is no consensus on the correct approach to medical management. The purpose of this report is to review a 14-year experience in the treatment of these patients comparing management schemes.
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Methods and Results. Between January 1978 and August 1988, 91 patients with tetralogy of Fallot and pulmonary atresia had an adequate evaluation of their pulmonary artery anatomy before any surgical management. Forty-eight of these patients had diminutive pulmonary arteries (38 to 104 mm2/m2) supplied by aortopulmonary collaterals and were managed in four different fashions. Of the 9 patients repaired primarily, 7 died early and the two survivors had poor hemodynamic outcome. Of the 9 patients conservatively managed with no intervention before 5 years of age, 4 died and only 1 had a satisfactory hemodynamic result after repair. Of 10 shunted patients, 3 died and 3 had satisfactory repairs. Since 1984, we have rehabilitated pulmonary arteries with (1) right ventricle to pulmonary artery surgical graft, (2) balloon dilation of residual pulmonary artery stenoses and embolization of collaterals, and (3) surgical closure of ventricular septal defect and repair of remaining obstructions. Of 20 patients so managed, 7 died after various stages, but 10 of 20 had complete repairs. All 12 have since undergone repair, including closure of their VSDs, with 2 perioperative deaths. Nine of the 10 surviving repaired patients (90%) had coil embolization (Fig 1) , and all underwent successful pulmonary artery dilation procedures (Fig 2) either before7 or after3 VSD closure. Successful pulmonary artery rehabilitation was achieved even in 3 patients with an initial PAI of <20 mm2/m2. The overall mortality for this group was 35%, and the 10 repaired survivors survived at an average of 3.9 years after surgery. See also Fig 3 through and injection in the same vessel demonstrating complete occlusion after embolization with Gianturco coil (right, arrow).
among groups. Overall, 15% (4 of 27) of patients had significant neurodevelopmental delays ( Table 2) .
Review of Mortality Among Patients Undergoing Rehabilitation
The 7 patients who died during the rehabilitation process were reviewed in detail. Of the 4 patients who died during the initial outflow procedure, 2 deaths (early in the experience) were due to severe neurological deficits discovered early after surgery. These deficits were thought to have been due to collateral-induced, poor somatic perfusion during cardiopulmonary bypass. The technique for the initial outflow procedure was altered to reduce the potential for central nervous system hypoperfusion. Similarly, 1 of the patients who died at repair from severe central nervous system dysfunction had a moderate-sized (3 mm), unrecognized collateral arising from the base of the vertebral artery; the vessel was not closed before surgery. The patient with the angioplasty-induced aneurysm was dilated very soon (7 weeks) after creation of the homograft to pulmonary artery anastomosis, which, over the course of 3 months, progressively enlarged to encompass the entire front of the heart, including the left anterior descending coronary artery (injured at the time of attempted surgical repair).
Discussion
The review of our experience with TOF-PA covering the period of 1978 to 1988 supports several previous observations. Patients with TOF-PA and diminutive pulmonary arteries (PAI <90 mm2/m2) carry a much higher risk of mortality and morbidity; relatively few of these patients have adequate late results after repair. Clearly, primary repair in this group of patients proved far too risky and should be abandoned. Although the mortality rates (30% to 44%) did not differ significantly among the other three approaches (conservative treatment, shunts, staged combined therapy), there appeared to be an important difference in overall longterm outcome (Table 4 ). Only 1 of the 9 patients managed conservatively lived with a satisfactory outcome after repair, and only 1 additional patient in this group was potentially repairable. In contrast, 40% (8 of 20) of patients after staged procedures were successfully repaired.
The poor late outcome of patients conservatively managed for the first 5 years of life is largely attributable to the development of pulmonary vascular obstructive disease (4 of 9, 44%). There is some evidence that infants with pulmonary atresia, and hence decreased intrauterine pulmonary blood flow, develop fewer pulmonary arterioles when compared with patients with normal pulmonary blood flow.13 Furthermore, in patients with unobstructed collateral flow, proliferative changes appear early in the distal pulmonary arterioles,14 whereas in areas of lung supplied by stenosed collateral, a decreased number of microvessels may develop. Shunts patients. An additional important advantage of creating right ventricular to pulmonary artery continuity early in life is that it allows access to pulmonary arteries for balloon dilation of peripheral stenotic vessels,17 which appears to be necessary for a successful outcome in the overwhelming majority of these patients. The precise identification of native pulmonary artery segmental distribution can be made most accurately after adequate flow is provided to central pulmonary arteries. The latter can best be assessed by selective injections into the distal pulmonary artery tree (Fig 2) . Finally, the staged approach allows selection of patients for final repair based on more complete physiological and anatomic data. Since most aortopulmonary collaterals can be closed by embolization,8 eventually most or all pulmonary blood flow in these patients will be supplied antegradely through the right ventricular outflow tract. Hence, any patient with TOF-PA who develops a net left-to-right shunt must have greater than systemic flow through mediastinal pulmonary arteries and should therefore tolerate VSD closure. This approach obviates the need for relying solely on measurements of pulmonary artery size to determine who might be an appropriate candidate for complete repair. 18 This staged approach was originally based on several hypotheses: (1) increased flow through central pulmonary arteries encourages increases in vessel size and also angiogenesis of distal microvessels, whereas decreased pulmonary artery flow has the opposite effect, (2) these phenomena are most important early in life, and (3) aortopulmonary collaterals are unreliable sources of pulmonary blood flow because the stenoses that are often present19,20 are not amenable to repair or dilation; when unobstructed, these vessels lead to early distal obstructive changes. The relatively high success rate, in this first study of its kind bringing these patients to a satisfactory repair, appear to support these hypotheses.
Despite these advantages of the staged approach, which appears likely to allow ultimately successful repair in at least half of the patients with TOF-PA and diminutive pulmonary arteries, several important issues remain unsolved: (1) precise preoperative quantification of pulmonary arteries too small to permit primary repair remains uncertain, (2) the optimum timing for outflow tract creation, pulmonary artery dilations, and collateral embolizations is unclear, (3) the role for unifocalization, although necessary in some patients, remains uncertain, and (4) optimal methods for intraoperative protection of the myocardium and also of the central nervous system requires a clearer understanding at the cellular or ultrastructural level. Although the overall mortality rate (35%) was quite high, 4 of the 7 deaths can be attributed to inexperience with the process and may be avoidable. It is difficult to draw firm conclusions from this initial procedure description for several reasons. There was a small number of patients in each subgroup, and lesions were heterogeneous. Important variables, including pulmonary artery size and distribution, number and distribution of multiple aortopulmonary collaterals, and age at surgical intervention, will need to be subjected to a more rigorous statistical analysis based on outcome variables. Biases may have been reinforced by dividing patients into anatomic and treatment categories to facilitate this study. Although this analysis has not permitted a definition of the optimal treatment for TOF-PA and diminutive pulmonary arteries, establishment of early right ventricle to pulmonary artery continuity with subsequent pulmonary artery dilations and collateral embolization has permitted eventual successful repair in a large percentage of patients. At the present time, we favor this management protocol. We anticipate that this alternative approach, which relies heavily on collaboration regarding decisions and management steps between cardiac surgeons and interventional cardiologists, will eventually allow successful repair in the large majority of patients with TOF-PA and diminutive pulmonary arteries. Since the overall results using the other treatment modalities have been for the most part inadequate, we believe that these preliminary results justify further exploration of early staged repair.
